Portage Biotech (PRTG)
(Delayed Data from NSDQ)
$0.26 USD
-0.01 (-4.08%)
Updated May 17, 2024 03:59 PM ET
After-Market: $0.26 0.00 (1.52%) 7:58 PM ET
NA Value
NA Growth NA Momentum NA VGMFundamental Charts
About Price to Cash Flow
The Price to Cash Flow ratio or P/CF is price divided by its cash flow per share. It's another great way to determine whether a company is undervalued or overvalued with the denominator being cash flow. One of the reasons why some investors prefer the P/CF ratio over the P/E ratio is because the net income of the cash flow portion rightly adds depreciation and amortization back in since these are not cash expenditures. In contrast, the net income that goes into the earnings portion of the P/E ratio does not add these in, thus artificially reducing the income and skewing the P/E ratio. Like the P/E ratio, a lower number is considered better. A value under 20 is generally considered good.
PRTG 0.26 -0.01(-4.08%)
Will PRTG be a Portfolio Killer in May?
Zacks Investment Research is releasing its prediction for PRTG based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for PRTG
New Strong Buy Stocks for January 26th
Best Momentum Stocks to Buy for January 20th
PRTG: What are Zacks experts saying now?
Zacks Private Portfolio Services
New Strong Buy Stocks for January 20th
How Much Upside is Left in Portage Biotech Inc. (PRTG)? Wall Street Analysts Think 160%
New Strong Buy Stocks for November 1st
Other News for PRTG
12 Health Care Stocks Moving In Monday's Pre-Market Session
Why JanOne Shares Are Trading Higher By 19%; Here Are 20 Stocks Moving Premarket
12 Health Care Stocks Moving In Friday's Intraday Session
Portage Biotech Announces Board Changes
12 Health Care Stocks Moving In Friday's After-Market Session